Both GSTM2 and GSTP1 promoters were among the top 1% of promoters whose methylation is most strongly correlated with TMB in prostate cancer (Supplementary Figure S7C) demonstrating that this association is specific for these genes. The gene discussed is GSTM2; the disease is prostate carcinoma.